MXPA01004828A - An inhalation system. - Google Patents

An inhalation system.


Publication number
MXPA01004828A MXPA01004828A MXPA01004828A MXPA01004828A MX PA01004828 A MXPA01004828 A MX PA01004828A MX PA01004828 A MXPA01004828 A MX PA01004828A MX PA01004828 A MXPA01004828 A MX PA01004828A MX PA01004828 A MXPA01004828 A MX PA01004828A
Prior art keywords
inhalation system
Prior art date
Application number
Other languages
Spanish (es)
Frank G Pilkiewicz
Original Assignee
Frank G Pilkiewicz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10806798P priority Critical
Priority to US10812698P priority
Application filed by Frank G Pilkiewicz filed Critical Frank G Pilkiewicz
Priority to PCT/US1999/026858 priority patent/WO2000027359A1/en
Publication of MXPA01004828A publication Critical patent/MXPA01004828A/en



    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy


An inhalation system of a composition having lipids and a bioactive agent and an inhalation device.
MXPA01004828A 1998-11-12 1999-11-12 An inhalation system. MXPA01004828A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10806798P true 1998-11-12 1998-11-12
US10812698P true 1998-11-12 1998-11-12
PCT/US1999/026858 WO2000027359A1 (en) 1998-11-12 1999-11-12 An inhalation system

Publications (1)

Publication Number Publication Date
MXPA01004828A true MXPA01004828A (en) 2002-09-18



Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01004828A MXPA01004828A (en) 1998-11-12 1999-11-12 An inhalation system.

Country Status (15)

Country Link
EP (1) EP1128813B1 (en)
JP (1) JP2002529393A (en)
CN (1) CN100358494C (en)
AT (1) AT353630T (en)
AU (1) AU766703B2 (en)
CA (1) CA2351063A1 (en)
CZ (1) CZ20011581A3 (en)
DE (1) DE69935154T2 (en)
ES (1) ES2281199T3 (en)
HU (1) HU0104255A3 (en)
IL (1) IL143046D0 (en)
MX (1) MXPA01004828A (en)
NZ (1) NZ511568A (en)
PL (1) PL347630A1 (en)
WO (1) WO2000027359A1 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
EP1036561A1 (en) 1997-10-01 2000-09-20 Flemington Pharmaceutical Corporation Buccal, non-polar spray
EP1109533A1 (en) * 1999-07-08 2001-06-27 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of National Defence Of Her Majesty's Canadian Gov. Pulmonary delivery of liposome-encapsulated cannabinoids
US6747058B1 (en) 1999-08-20 2004-06-08 Unimed Pharmaceuticals, Inc. Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
US7648696B2 (en) 1999-08-20 2010-01-19 Unimed Pharmaceuticals, Llc Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
US6645467B2 (en) * 1999-11-28 2003-11-11 Scientific Development And Research, Inc. Composition and method for decreasing upper respiratory airway resistance
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
JP2004517127A (en) 2000-12-21 2004-06-10 ネクター セラピューティックス Pulmonary delivery of polyene antifungal agent
CN100345549C (en) * 2001-05-02 2007-10-31 诺瓦提斯公司 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
DE60227660D1 (en) * 2001-05-24 2008-08-28 Alexza Pharmaceuticals Inc Release of antiemetics by the inhalation route
EP1392262A1 (en) 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20030059375A1 (en) * 2001-08-20 2003-03-27 Transave, Inc. Method for treating lung cancers
IL161733D0 (en) 2001-11-02 2005-11-20 Insert Therapeutics Inc Methods and compositions for therapeutic use of rna interference
US9186322B2 (en) 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
SI1581236T1 (en) * 2002-10-29 2014-02-28 Insmed Incorporated Princeton Corporate Plaza Sustained release of antiinfectives
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
WO2004100928A1 (en) * 2003-05-09 2004-11-25 Novosom Ag Injectable liposomal depots for delivering active ingredients
EP1625333A1 (en) 2003-05-21 2006-02-15 Alexza Pharmaceuticals, Inc. Self-contained heating unit and drug-supply unit employing same
US20040265238A1 (en) 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
JP4649841B2 (en) * 2004-02-18 2011-03-16 コニカミノルタエムジー株式会社 METHOD FOR PRODUCING liposome-containing formulations, and liposome-containing formulations
ES2381201T3 (en) 2005-03-31 2012-05-24 Calando Pharmaceuticals, Inc. Inhibitors subunit 2 of ribonucleotide reductase and uses thereof
WO2007053696A2 (en) 2005-11-01 2007-05-10 Alnylam Pharmaceuticals, Inc. Rnai inhibition of influenza virus replication
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
CA2838111C (en) 2005-12-08 2016-01-19 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
WO2007109097A2 (en) 2006-03-16 2007-09-27 Alnylam Pharmaceuticals, Inc. RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF
AT528008T (en) 2006-05-19 2011-10-15 Alnylam Pharmaceuticals Inc Rnai-modulation of aha and their therapeutic use
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
WO2008137717A1 (en) 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
WO2009123764A2 (en) 2008-04-04 2009-10-08 Calando Pharmaceuticals, Inc. Compositions and use of epas1 inhibitors
WO2009143011A1 (en) * 2008-05-20 2009-11-26 Novartis Ag Antiviral compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions
CA2755809C (en) * 2009-03-18 2014-02-18 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
KR20130109106A (en) * 2010-08-05 2013-10-07 피라말 엔터프라이지즈 리미티드 Microparticle formulation for pulmonary drug delivery of anti-infective molecule for treatment of infectious diseases
NZ719739A (en) 2012-05-21 2017-07-28 Insmed Inc Systems for treating pulmonary infections
WO2014085526A1 (en) 2012-11-29 2014-06-05 Insmed Incorporated Stabilized vancomycin formulations
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
AU2014204733B2 (en) 2013-01-14 2016-09-08 Health Clinics Limited Cancer drug and uses
CA2910766A1 (en) 2013-04-30 2014-11-06 Otitopic Inc. Dry powder formulations and methods of use
JP2017506252A (en) 2014-02-20 2017-03-02 オティトピック インコーポレイテッド Dry powder formulations for inhalation
WO2015175939A1 (en) 2014-05-15 2015-11-19 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
JP6478959B2 (en) * 2016-09-07 2019-03-06 株式会社富士薬品 System and method for producing particle-containing composition
US10195147B1 (en) 2017-09-22 2019-02-05 Otitopic Inc. Dry powder compositions with magnesium stearate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8322178D0 (en) * 1983-08-17 1983-09-21 Sterwin Ag Preparing aerosol compositions
EP0223831B1 (en) * 1985-05-22 1992-07-15 Liposome Technology, Inc. Liposome inhalation method and system
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US5616334A (en) * 1987-03-05 1997-04-01 The Liposome Company, Inc. Low toxicity drug-lipid systems
CA2081474A1 (en) * 1990-05-08 1991-11-09 Manzer Durrani Direct spray-dried drug/lipid powder composition
US6001644A (en) * 1991-12-17 1999-12-14 The Regents Of The University Of California Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
US5756353A (en) * 1991-12-17 1998-05-26 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol-and liposome-based delivery
US5858784A (en) * 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
AR002009A1 (en) * 1994-12-22 1998-01-07 Astra Ab pharmaceutical composition, process for the manufacture of a proliposome powder as used in said composition, process for lamanufactura of said composition, use of said pharmaceutical composition in the manufacture of a medicament and dry powder inhaler device.

Also Published As

Publication number Publication date
EP1128813A4 (en) 2004-08-18
AT353630T (en) 2007-03-15
CZ20011581A3 (en) 2001-12-12
HU0104255A3 (en) 2002-12-28
PL347630A1 (en) 2002-04-22
EP1128813A1 (en) 2001-09-05
EP1128813B1 (en) 2007-02-14
ES2281199T3 (en) 2007-09-16
NZ511568A (en) 2003-08-29
DE69935154T2 (en) 2007-10-25
AU766703B2 (en) 2003-10-23
WO2000027359A1 (en) 2000-05-18
HU0104255A2 (en) 2002-03-28
CN1332626A (en) 2002-01-23
CN100358494C (en) 2008-01-02
CA2351063A1 (en) 2000-05-18
JP2002529393A (en) 2002-09-10
IL143046D0 (en) 2002-04-21
AU1621200A (en) 2000-05-29
DE69935154D1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
GB2297914B (en) Humidifier systems
EP1082072B8 (en) Endovascular thin film devices for treating and preventing stroke
GB2321356B (en) Source location system
GB2286832B (en) An absorbent body and apparatus for its manufacture
AU685986B2 (en) Thin absorbent article having wicking and crush resistant poperties
GB2298580B (en) An improved artificial airway device
AP1484A (en) System for contactles recogniton of hand and finerlines.
AU703128B2 (en) Device in inhalers
DE69619233D1 (en) Prrs-(porcine reproductive and respiratory syndrome)-virusvakzin
GB2321012B (en) Method for fighting against myases affecting cattle and sheep populations and compositions for implementing same
GB2297474B (en) Absorbent pants
IL108780A (en) Inhalation device
GB9516709D0 (en) Medicament
AU5924099A (en) Tissue fastening devices and delivery means
IL135360A (en) Body track dilation systems and related methods
MX9703947A (en) Stretchable absorbent article core.
AU6008898A (en) Single dose inhaler i
AU3699197A (en) Polynucleotide vaccine formula against porcine reproductive and respiratory pathologies
AU4127296A (en) Dose indicating device
AU1081499A (en) Delivery catheter for occlusive device
AU7674191A (en) Apparatus for providing enhanced tissue fragmentation and/or hemostasis
GR3021099T3 (en) An inhaling device
GB9626233D0 (en) Medicament packaging and deliveery device
AU6338396A (en) Intra-cavity therapeutic agent delivery device
TW353368U (en) Medicament inhaler and method